Tetraarsenic tetrasulfide
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Tetraarsenic tetrasulfide
- DrugBank Accession Number
- DB19141
- Background
Tetraarsenic tetrasulfide is under investigation in clinical trial NCT05682131 (South China Children Cancer Group - Relapsed-acute Lymphoblastic Leukemia 2022 Protocol).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 427.93
Monoisotopic: 427.574665 - Chemical Formula
- As4S4
- Synonyms
- Arsenic disulfide
- Arsenic disulphide
- Arsenic monosulfide
- Arsenic monosulphide
- Arsenic sulfide
- Arsenic sulfide red
- Arsenic sulphide red
- Arsenicum sulphuratum rubrum
- Arsino, thioxo-
- Realgar
- Red arsenic glass
- Ruby arsenic
- Tetra-arsenic tetra-sulfide
- Tetra-arsenic tetra-sulphide
- Tetraarsenic tetrasulphide
- Xionghuang
- External IDs
- C.I. 77085
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ZIK02R2PSD
- CAS number
- 12279-90-2
- InChI Key
- XPDICGYEJXYUDW-UHFFFAOYSA-N
- InChI
- InChI=1S/As4S4/c5-1-2-7-3(5)4(6-1)8-2
- IUPAC Name
- SMILES
- S1[As]2S[As]3S[As]2S[As]13
References
- General References
- Not Available
- External Links
- ChemSpider
- 122842
- 1426938
- Wikipedia
- Arsenic_sulfide
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Treatment Childhood Acute Promyelocytic Leukemia (M3) 1 somestatus stop reason just information to hide 4 Recruiting Treatment Arsenic Trioxide / Childhood Acute Lymphoblastic Leukemia 1 somestatus stop reason just information to hide 3 Not Yet Recruiting Treatment Acute Promyelocytic Leukemia 1 somestatus stop reason just information to hide 3 Recruiting Treatment Acute Promyelocytic Leukemia 1 somestatus stop reason just information to hide 3 Suspended Treatment Chronic Myelogenous Leukemia (CML) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 04, 2024 21:08 / Updated at July 05, 2024 04:36